112 related articles for article (PubMed ID: 11098500)
1. A phase I study of paclitaxel, UFT, and leucovorin.
Gojo I; Tkaczuk KH
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):76-8. PubMed ID: 11098500
[TBL] [Abstract][Full Text] [Related]
2. UFT/calcium folinate plus weekly paclitaxel for solid tumors.
Bokemeyer C; Hartmann JT; Kollmannsberger C; Mayer F; Kanz L
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):106-11. PubMed ID: 10442376
[TBL] [Abstract][Full Text] [Related]
3. UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors.
Bokemeyer C; Hartmann JT; Mayer F; Böhlke I; Kanz L; Von Pawel J; Derigs G; Schröder M
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):63-7. PubMed ID: 11098497
[TBL] [Abstract][Full Text] [Related]
4. A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer.
Scholz U; Lück HJ; Canzler U; Robner D; Kühnle H
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):44-6. PubMed ID: 11098492
[TBL] [Abstract][Full Text] [Related]
5. UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
Lück HJ; Scholz U; Kühnle H; Dethling J
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):74-6. PubMed ID: 10442368
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
[TBL] [Abstract][Full Text] [Related]
9. UFT/leucovorin plus irinotecan in advanced or metastatic colorectal cancer.
Price T; Hill M
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):28-31. PubMed ID: 11098487
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.
Passardi A; Maltoni R; Milandri C; Cecconetto L; Massa I; Zoli W; Tesei A; Fabbri F; Nanni O; Amadori D
Oncology; 2007; 72(1-2):118-24. PubMed ID: 18004083
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors.
Mayer F; Hartmann JT; von Pawel J; Beck J; Schroeder M; Boehlke I; Kanz L; Bokemeyer C;
Ann Oncol; 2002 May; 13(5):755-9. PubMed ID: 12075745
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan and UFT/leucovorin in patients with advanced cancers.
Stevenson JP; Redlinger M; Sun W; Haller D; O'Dwyer PJ
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):91-2. PubMed ID: 11098504
[TBL] [Abstract][Full Text] [Related]
14. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
16. UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.
Gregory RK; Johnston SR; Smith IE; Miles D
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):47-9. PubMed ID: 11098493
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days.
DeMario MD; Ratain MJ; Vogelzang NJ; Mani S; Vokes EE; Fleming GF; Melton K; Johnson S; Benner S; Lebwohl D
Cancer Chemother Pharmacol; 1999; 43(5):385-8. PubMed ID: 10100593
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
19. A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
Hortobagyi GN; Heim W; Hutchins L; Rivera E; Mason B; Booser DJ; Kirshner J
Cancer; 2010 Mar; 116(6):1440-5. PubMed ID: 20091835
[TBL] [Abstract][Full Text] [Related]
20. Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):35-9. PubMed ID: 9348565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
